Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 91

1.

Review of recent applications and research progress in hybrid and combined microwave-assisted drying of food products: Quality properties.

Zielinska M, Ropelewska E, Xiao HW, Mujumdar AS, Law CL.

Crit Rev Food Sci Nutr. 2019 Jul 1:1-53. doi: 10.1080/10408398.2019.1632788. [Epub ahead of print]

PMID:
31257908
2.

Liquid Biphasic Electric Partitioning System as a Novel Integration Process for Betacyanins Extraction From Red-Purple Pitaya and Antioxidant Properties Assessment.

Leong HY, Chang YK, Ooi CW, Law CL, Julkifle AL, Show PL.

Front Chem. 2019 Apr 3;7:201. doi: 10.3389/fchem.2019.00201. eCollection 2019.

3.

NMR resonance assignments and secondary structure of a mutant form of the human KCNE1 channel accessory protein that exhibits KCNE3-like function.

Law CL, Sanders CR.

Biomol NMR Assign. 2019 Apr;13(1):143-147. doi: 10.1007/s12104-018-09867-6. Epub 2019 Jan 2.

PMID:
30603955
4.

Unrecognized Elevations of Toxic Elements in Urine and Blood Highlight the Potential Need for a Broader Approach to Exposure Assessment.

Hackenmueller SA, Gherasim C, Walden JQ, Law CL, Strathmann FG.

J Anal Toxicol. 2019 May 1;43(4):284-290. doi: 10.1093/jat/bky089.

PMID:
30476143
5.

Development of Aurantiochytrium limacinum SR21 cultivation using salt-rich waste feedstock for docosahexaenoic acid production and application of natural colourant in food product.

Leong HY, Su CA, Lee BS, Lan JC, Law CL, Chang JS, Show PL.

Bioresour Technol. 2019 Jan;271:30-36. doi: 10.1016/j.biortech.2018.09.093. Epub 2018 Sep 19.

PMID:
30261334
6.

Characterization of edible bird's nest of different production, species and geographical origins using nutritional composition, physicochemical properties and antioxidant activities.

Quek MC, Chin NL, Yusof YA, Law CL, Tan SW.

Food Res Int. 2018 Jul;109:35-43. doi: 10.1016/j.foodres.2018.03.078. Epub 2018 Mar 31.

PMID:
29803459
7.

Characterization of SGN-CD123A, A Potent CD123-Directed Antibody-Drug Conjugate for Acute Myeloid Leukemia.

Li F, Sutherland MK, Yu C, Walter RB, Westendorf L, Valliere-Douglass J, Pan L, Cronkite A, Sussman D, Klussman K, Ulrich M, Anderson ME, Stone IJ, Zeng W, Jonas M, Lewis TS, Goswami M, Wang SA, Senter PD, Law CL, Feldman EJ, Benjamin DR.

Mol Cancer Ther. 2018 Feb;17(2):554-564. doi: 10.1158/1535-7163.MCT-17-0742. Epub 2017 Nov 15.

8.

Peripheral myelin protein 22 alters membrane architecture.

Mittendorf KF, Marinko JT, Hampton CM, Ke Z, Hadziselimovic A, Schlebach JP, Law CL, Li J, Wright ER, Sanders CR, Ohi MD.

Sci Adv. 2017 Jul 5;3(7):e1700220. doi: 10.1126/sciadv.1700220. eCollection 2017 Jul.

9.

Tumor-Associated Macrophages Can Contribute to Antitumor Activity through FcγR-Mediated Processing of Antibody-Drug Conjugates.

Li F, Ulrich M, Jonas M, Stone IJ, Linares G, Zhang X, Westendorf L, Benjamin DR, Law CL.

Mol Cancer Ther. 2017 Jul;16(7):1347-1354. doi: 10.1158/1535-7163.MCT-17-0019. Epub 2017 Mar 24.

10.

Performance and kinetic evaluation of an integrated anaerobic-aerobic bioreactor in the treatment of palm oil mill effluent.

Chan YJ, Chong MF, Law CL.

Environ Technol. 2017 Apr;38(8):1005-1021. doi: 10.1080/09593330.2016.1217053. Epub 2016 Aug 17.

PMID:
27532518
11.

Intracellular Released Payload Influences Potency and Bystander-Killing Effects of Antibody-Drug Conjugates in Preclinical Models.

Li F, Emmerton KK, Jonas M, Zhang X, Miyamoto JB, Setter JR, Nicholas ND, Okeley NM, Lyon RP, Benjamin DR, Law CL.

Cancer Res. 2016 May 1;76(9):2710-9. doi: 10.1158/0008-5472.CAN-15-1795. Epub 2016 Feb 26.

12.

The performance of anal cytology as a screening test for anal HSILs in homosexual men.

Jin F, Grulich AE, Poynten IM, Hillman RJ, Templeton DJ, Law CL, Farnsworth A, Garland SM, Fairley CK, Roberts JM; SPANC Study Team.

Cancer Cytopathol. 2016 Jun;124(6):415-24. doi: 10.1002/cncy.21702. Epub 2016 Feb 24.

13.

Stimulus characteristics affect assessment of pupil defects in amblyopia.

Law CL, Siu M, Modica P, Backus B.

Optom Vis Sci. 2015 May;92(5):551-8. doi: 10.1097/OPX.0000000000000576.

PMID:
25875680
14.

Purification and structural study of the voltage-sensor domain of the human KCNQ1 potassium ion channel.

Peng D, Kim JH, Kroncke BM, Law CL, Xia Y, Droege KD, Van Horn WD, Vanoye CG, Sanders CR.

Biochemistry. 2014 Apr 1;53(12):2032-42. doi: 10.1021/bi500102w. Epub 2014 Mar 18.

15.

Colour, phenolic content and antioxidant capacity of some fruits dehydrated by a combination of different methods.

Chong CH, Law CL, Figiel A, Wojdyło A, Oziembłowski M.

Food Chem. 2013 Dec 15;141(4):3889-96. doi: 10.1016/j.foodchem.2013.06.042. Epub 2013 Jun 27.

PMID:
23993562
16.

A potent anti-CD70 antibody-drug conjugate combining a dimeric pyrrolobenzodiazepine drug with site-specific conjugation technology.

Jeffrey SC, Burke PJ, Lyon RP, Meyer DW, Sussman D, Anderson M, Hunter JH, Leiske CI, Miyamoto JB, Nicholas ND, Okeley NM, Sanderson RJ, Stone IJ, Zeng W, Gregson SJ, Masterson L, Tiberghien AC, Howard PW, Thurston DE, Law CL, Senter PD.

Bioconjug Chem. 2013 Jul 17;24(7):1256-63. doi: 10.1021/bc400217g. Epub 2013 Jun 28.

PMID:
23808985
17.

Development of orally active inhibitors of protein and cellular fucosylation.

Okeley NM, Alley SC, Anderson ME, Boursalian TE, Burke PJ, Emmerton KM, Jeffrey SC, Klussman K, Law CL, Sussman D, Toki BE, Westendorf L, Zeng W, Zhang X, Benjamin DR, Senter PD.

Proc Natl Acad Sci U S A. 2013 Apr 2;110(14):5404-9. doi: 10.1073/pnas.1222263110. Epub 2013 Mar 14.

18.

Start-up, steady state performance and kinetic evaluation of a thermophilic integrated anaerobic-aerobic bioreactor (IAAB).

Chan YJ, Chong MF, Law CL.

Bioresour Technol. 2012 Dec;125:145-57. doi: 10.1016/j.biortech.2012.08.118. Epub 2012 Aug 31.

PMID:
23026327
19.

Preliminary results of dancing exercise on postural stability in adolescent females.

Cheng HS, Law CL, Pan HF, Hsiao YP, Hu JH, Chuang FK, Huang MH.

Kaohsiung J Med Sci. 2011 Dec;27(12):566-72. doi: 10.1016/j.kjms.2011.06.032. Epub 2011 Nov 30.

20.

Distinct apoptotic signaling characteristics of the anti-CD40 monoclonal antibody dacetuzumab and rituximab produce enhanced antitumor activity in non-Hodgkin lymphoma.

Lewis TS, McCormick RS, Emmerton K, Lau JT, Yu SF, McEarchern JA, Grewal IS, Law CL.

Clin Cancer Res. 2011 Jul 15;17(14):4672-81. doi: 10.1158/1078-0432.CCR-11-0479. Epub 2011 May 24.

21.

Proapoptotic signaling activity of the anti-CD40 monoclonal antibody dacetuzumab circumvents multiple oncogenic transformation events and chemosensitizes NHL cells.

Lewis TS, McCormick RS, Stone IJ, Emmerton K, Mbow B, Miyamoto J, Drachman JG, Grewal IS, Law CL.

Leukemia. 2011 Jun;25(6):1007-16. doi: 10.1038/leu.2011.21. Epub 2011 Mar 11.

PMID:
21394099
22.

Improving Malaysian cocoa quality through the use of dehumidified air under mild drying conditions.

Hii CL, Law CL, Cloke M, Sharif S.

J Sci Food Agric. 2011 Jan 30;91(2):239-46. doi: 10.1002/jsfa.4176.

PMID:
20872824
23.

Targeting pancreatic and ovarian carcinomas using the auristatin-based anti-CD70 antibody-drug conjugate SGN-75.

Ryan MC, Kostner H, Gordon KA, Duniho S, Sutherland MK, Yu C, Kim KM, Nesterova A, Anderson M, McEarchern JA, Law CL, Smith LM.

Br J Cancer. 2010 Aug 24;103(5):676-84. doi: 10.1038/sj.bjc.6605816. Epub 2010 Jul 27.

24.

5-azacytidine enhances the anti-leukemic activity of lintuzumab (SGN-33) in preclinical models of acute myeloid leukemia.

Sutherland MK, Yu C, Anderson M, Zeng W, van Rooijen N, Sievers EL, Grewal IS, Law CL.

MAbs. 2010 Jul-Aug;2(4):440-8. Epub 2010 Jul 1.

25.

Biological treatment of anaerobically digested palm oil mill effluent (POME) using a Lab-Scale Sequencing Batch Reactor (SBR).

Chan YJ, Chong MF, Law CL.

J Environ Manage. 2010 Aug;91(8):1738-46. doi: 10.1016/j.jenvman.2010.03.021. Epub 2010 Apr 28.

PMID:
20430515
26.

Anti-leukemic activity of lintuzumab (SGN-33) in preclinical models of acute myeloid leukemia.

Sutherland MK, Yu C, Lewis TS, Miyamoto JB, Morris-Tilden CA, Jonas M, Sutherland J, Nesterova A, Gerber HP, Sievers EL, Grewal IS, Law CL.

MAbs. 2009 Sep-Oct;1(5):481-90. Epub 2009 Sep 15.

27.

Targeting CD70 for human therapeutic use.

Boursalian TE, McEarchern JA, Law CL, Grewal IS.

Adv Exp Med Biol. 2009;647:108-19. doi: 10.1007/978-0-387-89520-8_7. Review.

PMID:
19760069
28.

Therapeutic interventions targeting CD40L (CD154) and CD40: the opportunities and challenges.

Law CL, Grewal IS.

Adv Exp Med Biol. 2009;647:8-36. doi: 10.1007/978-0-387-89520-8_2. Review.

PMID:
19760064
29.

Blocking of CD27-CD70 pathway by anti-CD70 antibody ameliorates joint disease in murine collagen-induced arthritis.

Oflazoglu E, Boursalian TE, Zeng W, Edwards AC, Duniho S, McEarchern JA, Law CL, Gerber HP, Grewal IS.

J Immunol. 2009 Sep 15;183(6):3770-7. doi: 10.4049/jimmunol.0901637. Epub 2009 Aug 26.

30.

The pharmacologic basis for antibody-auristatin conjugate activity.

Alley SC, Zhang X, Okeley NM, Anderson M, Law CL, Senter PD, Benjamin DR.

J Pharmacol Exp Ther. 2009 Sep;330(3):932-8. doi: 10.1124/jpet.109.155549. Epub 2009 Jun 4.

PMID:
19498104
31.

Novel antibody-based therapeutic agents targeting CD70: a potential approach for treating Waldenström's macroglobulinemia.

Law CL, McEarchern JA, Grewal IS.

Clin Lymphoma Myeloma. 2009 Mar;9(1):90-3. doi: 10.3816/CLM.2009.n.024. Review.

PMID:
19362984
32.

Macrophages and Fc-receptor interactions contribute to the antitumour activities of the anti-CD40 antibody SGN-40.

Oflazoglu E, Stone IJ, Brown L, Gordon KA, van Rooijen N, Jonas M, Law CL, Grewal IS, Gerber HP.

Br J Cancer. 2009 Jan 13;100(1):113-7. doi: 10.1038/sj.bjc.6604812. Epub 2008 Dec 9.

33.

Preclinical characterization of SGN-70, a humanized antibody directed against CD70.

McEarchern JA, Smith LM, McDonagh CF, Klussman K, Gordon KA, Morris-Tilden CA, Duniho S, Ryan M, Boursalian TE, Carter PJ, Grewal IS, Law CL.

Clin Cancer Res. 2008 Dec 1;14(23):7763-72. doi: 10.1158/1078-0432.CCR-08-0493.

34.

Potent anticarcinoma activity of the humanized anti-CD70 antibody h1F6 conjugated to the tubulin inhibitor auristatin via an uncleavable linker.

Oflazoglu E, Stone IJ, Gordon K, Wood CG, Repasky EA, Grewal IS, Law CL, Gerber HP.

Clin Cancer Res. 2008 Oct 1;14(19):6171-80. doi: 10.1158/1078-0432.CCR-08-0916. Epub 2008 Sep 22.

35.

CD27-CD70 interactions in the pathogenesis of Waldenstrom macroglobulinemia.

Ho AW, Hatjiharissi E, Ciccarelli BT, Branagan AR, Hunter ZR, Leleu X, Tournilhac O, Xu L, O'Connor K, Manning RJ, Santos DD, Chemaly M, Patterson CJ, Soumerai JD, Munshi NC, McEarchern JA, Law CL, Grewal IS, Treon SP.

Blood. 2008 Dec 1;112(12):4683-9. doi: 10.1182/blood-2007-04-084525. Epub 2008 Jan 23.

36.

Macrophages contribute to the antitumor activity of the anti-CD30 antibody SGN-30.

Oflazoglu E, Stone IJ, Gordon KA, Grewal IS, van Rooijen N, Law CL, Gerber HP.

Blood. 2007 Dec 15;110(13):4370-2. Epub 2007 Oct 1.

PMID:
17909075
37.

Engineered anti-CD70 antibody with multiple effector functions exhibits in vitro and in vivo antitumor activities.

McEarchern JA, Oflazoglu E, Francisco L, McDonagh CF, Gordon KA, Stone I, Klussman K, Turcott E, van Rooijen N, Carter P, Grewal IS, Wahl AF, Law CL.

Blood. 2007 Feb 1;109(3):1185-92. Epub 2006 Oct 12.

PMID:
17038522
38.

Lymphocyte activation antigen CD70 expressed by renal cell carcinoma is a potential therapeutic target for anti-CD70 antibody-drug conjugates.

Law CL, Gordon KA, Toki BE, Yamane AK, Hering MA, Cerveny CG, Petroziello JM, Ryan MC, Smith L, Simon R, Sauter G, Oflazoglu E, Doronina SO, Meyer DL, Francisco JA, Carter P, Senter PD, Copland JA, Wood CG, Wahl AF.

Cancer Res. 2006 Feb 15;66(4):2328-37.

39.

Lysosomal trafficking and cysteine protease metabolism confer target-specific cytotoxicity by peptide-linked anti-CD30-auristatin conjugates.

Sutherland MS, Sanderson RJ, Gordon KA, Andreyka J, Cerveny CG, Yu C, Lewis TS, Meyer DL, Zabinski RF, Doronina SO, Senter PD, Law CL, Wahl AF.

J Biol Chem. 2006 Apr 14;281(15):10540-7. Epub 2006 Feb 16.

40.

Preclinical antilymphoma activity of a humanized anti-CD40 monoclonal antibody, SGN-40.

Law CL, Gordon KA, Collier J, Klussman K, McEarchern JA, Cerveny CG, Mixan BJ, Lee WP, Lin Z, Valdez P, Wahl AF, Grewal IS.

Cancer Res. 2005 Sep 15;65(18):8331-8. Erratum in: Cancer Res. 2006 Feb 15;66(4):2495.

41.

Signaling via the anti-CD30 mAb SGN-30 sensitizes Hodgkin's disease cells to conventional chemotherapeutics.

Cerveny CG, Law CL, McCormick RS, Lenox JS, Hamblett KJ, Westendorf LE, Yamane AK, Petroziello JM, Francisco JA, Wahl AF.

Leukemia. 2005 Sep;19(9):1648-55.

PMID:
16049514
42.

Efficient elimination of B-lineage lymphomas by anti-CD20-auristatin conjugates.

Law CL, Cerveny CG, Gordon KA, Klussman K, Mixan BJ, Chace DF, Meyer DL, Doronina SO, Siegall CB, Francisco JA, Senter PD, Wahl AF.

Clin Cancer Res. 2004 Dec 1;10(23):7842-51. Erratum in: Clin Cancer Res. 2005 May 15;11(10):3969.

43.

Suppression subtractive hybridization and expression profiling identifies a unique set of genes overexpressed in non-small-cell lung cancer.

Petroziello J, Yamane A, Westendorf L, Thompson M, McDonagh C, Cerveny C, Law CL, Wahl A, Carter P.

Oncogene. 2004 Oct 7;23(46):7734-45.

PMID:
15334068
44.

Differential control of CD22 ligand expression on B and T lymphocytes, and enhanced expression in murine systemic lupus.

Lajaunias F, Ida A, Kikuchi S, Fossati-Jimack L, Martinez-Soria E, Moll T, Law CL, Izui S.

Arthritis Rheum. 2003 Jun;48(6):1612-21.

45.

cAC10-vcMMAE, an anti-CD30-monomethyl auristatin E conjugate with potent and selective antitumor activity.

Francisco JA, Cerveny CG, Meyer DL, Mixan BJ, Klussman K, Chace DF, Rejniak SX, Gordon KA, DeBlanc R, Toki BE, Law CL, Doronina SO, Siegall CB, Senter PD, Wahl AF.

Blood. 2003 Aug 15;102(4):1458-65. Epub 2003 Apr 24.

PMID:
12714494
46.

Expression and characterization of recombinant soluble human CD3 molecules: presentation of antigenic epitopes defined on the native TCR-CD3 complex.

Law CL, Hayden-Ledbetter M, Buckwalter S, McNeill L, Nguyen H, Habecker P, Thorne BA, Dua R, Ledbetter JA.

Int Immunol. 2002 Apr;14(4):389-400.

PMID:
11934875
47.

FcgammaRII tyrosine phosphorylation differs between FcgammaRII cross-linking and platelet-activating anti-platelet monoclonal antibodies.

Qi R, Ozaki Y, Asazuma N, Satoh K, Yatomi Y, Law CL, Hato T, Nomura S.

Biochim Biophys Acta. 1999 Sep 21;1451(2-3):353-63.

48.

CDw150 associates with src-homology 2-containing inositol phosphatase and modulates CD95-mediated apoptosis.

Mikhalap SV, Shlapatska LM, Berdova AG, Law CL, Clark EA, Sidorenko SP.

J Immunol. 1999 May 15;162(10):5719-27.

49.

GrpL, a Grb2-related adaptor protein, interacts with SLP-76 to regulate nuclear factor of activated T cell activation.

Law CL, Ewings MK, Chaudhary PM, Solow SA, Yun TJ, Marshall AJ, Hood L, Clark EA.

J Exp Med. 1999 Apr 19;189(8):1243-53.

50.

Isolation of Serpulina pilosicoli from rectal biopsy specimens showing evidence of intestinal spirochetosis.

Trivett-Moore NL, Gilbert GL, Law CL, Trott DJ, Hampson DJ.

J Clin Microbiol. 1998 Jan;36(1):261-5.

Supplemental Content

Support Center